Company news
Insight Molecular Diagnostics Inc. news in 2025
Insight Molecular Diagnostics Inc.'s news releases, calls and decks from 2025, newest first.
TitleNominating and Corporate Governance Charter
December 18, 2025
TitleCompensation Committee Charter
December 18, 2025
TitleAudit Committee Charter
December 18, 2025
IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch
November 9, 2025
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week
November 3, 2025
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch
October 12, 2025
iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset’ with Novel Therapy and GraftAssure Monitoring
October 6, 2025
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando
September 24, 2025
Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database
September 7, 2025
IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants
September 7, 2025
iMDx to Participate in NYC Investment Conferences September 8 - 11
August 26, 2025
IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics
August 25, 2025
IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch
August 11, 2025
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference
August 4, 2025
IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients
July 30, 2025
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025
July 28, 2025
iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing
June 23, 2025
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
June 16, 2025
Calls in 2025
Decks in 2025
- H.C. Wainwright 27th Annual Global Investment Conference 2025
Conference · 12 slides · September 2025
- Investor Presentation (August 2025)
Investor deck · 15 slides · Aug 15, 2025
- Investor Presentation (August 2025)
Investor deck · 46 slides · August 2025
- Investor Presentation (June 2025)
Investor deck · 46 slides · June 2025
- Oncocyte — Investor Presentation (March 2025)
Investor deck · 46 slides · March 2025